الإحصائيات الأساسية
| LEI | 391200FXBJCM5THDSO98 |
| CIK | 1158399 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Burcon NutraScience Corporation
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| November 20, 2024 |
Burcon NutraScience Corporation Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and six months ended September 30, 2024 and 2023 (Unaudited) (In Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Statements of Financial Position (Unaudited) As at September 30, 2024 and March 31, 2024 (In Canadian dollars) September 30, 2024 March 31, 2024 ASSETS Current asse |
|
| November 20, 2024 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and six months ended September 30, 2024 and 2023 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| November 20, 2024 |
Burcon Announces Rights Offering News Release Burcon Announces Rights Offering Vancouver, British Columbia, November 20, 2024 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (OTCQB: BRCNF), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it will be offering rights (the "Rights Offering") to holders of its common shares ("Common Shares") of record at the close of business on November 27, 2024 (the "Record Date") in eligible jurisdictions. |
|
| November 20, 2024 |
As filed with the Securities and Exchange Commission on November 20, 2024 Registration Statement No. |
|
| November 20, 2024 |
Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2024 and 2023 (in Canadian dollars) KPMG LLP PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Canada Telephone (604) 691-3000 Fax (604) 691-3031 INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Burcon NutraScience Corporation Opinion We have audited the consolidated financial statements of Burcon NutraScience |
|
| November 20, 2024 |
BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, B.C. V6J 1Z2 CANADA Telephone: (604) 733-0896 Facsimile: (604) 733-8821 ANNUAL INFORMATION FORM FOR THE YEAR ENDED MARCH 31, 2024 June 26, 2024 Table of Contents PRELIMINARY NOTES 1 Effective Date of Information 1 Forward Looking Statements 1 Currency 4 CORPORATE STRUCTURE 5 INTERCORPORATE RELATIONSHIPS 5 GENERAL DEVELOPMENT OF THE BUSI |
|
| November 20, 2024 |
Consent of Independent Registered Public Accounting Firm KPMG LLP Chartered Professional Accountants PO Box 10426 777 Dunsmuir Street Vancouver BC V7Y 1K3 Telephone (604) 691-3000 Fax (604) 691-3031 www. |
|
| November 20, 2024 |
BURCON NUTRASCIENCE CORPORATION Notice of Annual General and Special Meeting of Shareholders to be held on September 18, 2024 Management Proxy Circular TABLE OF CONTENTS LETTER TO SHAREHOLDERS 1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS 1 MANAGEMENT PROXY CIRCULAR 1 GENERAL PROXY INFORMATION 1 Who Can Vote 1 Obtaining a Paper Copy of Management Proxy Circular and Financial State |
|
| November 20, 2024 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Years ended March 31, 2024 and 2023 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| August 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| September 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-35289 Burcon NutraScience Corporation NASDAQ CAPITAL MARKET (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |
|
| September 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 6, 2022 |
Burcon Issues Shareholder Letter News Release Burcon Issues Shareholder Letter Vancouver, British Columbia, September 6, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today issued a letter to shareholders from its Interim CEO and Chairman of the Board, Peter H. |
|
| September 2, 2022 |
Burcon Announces Delisting from Nasdaq Capital Market News Release Burcon Announces Delisting from Nasdaq Capital Market Vancouver, British Columbia, September 2, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it intends to file a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) with the Securities and Exchange Commission (the "SEC") on September 12, 2022 to delist the Company's common shares from the Nasdaq Capital Market and to deregister its common shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). |
|
| September 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 2, 2022 |
Burcon Announces Auditor Resignation and AGM Postponement News Release Burcon Announces Auditor Resignation and AGM Postponement Vancouver, British Columbia, September 2, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced the resignation of its auditors, PricewaterhouseCoopers LLP ("PwC"), effective September 1, 2022 and that it is postponing its annual meeting of shareholders (the "AGM"), which was to be held on September 14, 2022. |
|
| September 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 15, 2022 |
Burcon NutraScience Corporation Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three months ended June 30, 2022 and 2021 (Unaudited) (In Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at June 30, 2022 and March 31, 2022 (In Canadian dollars) June 30, 2022 $ March 31, 2022 $ ASSETS Current assets Cash and cash equivalents 1,641,12 |
|
| August 15, 2022 |
Burcon Reports Fiscal 2023 First Quarter Results News Release Burcon Reports Fiscal 2023 First Quarter Results Vancouver, British Columbia, August 15, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal first quarter ended June 30, 2022. |
|
| August 15, 2022 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Peter H. |
|
| August 15, 2022 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. |
|
| August 15, 2022 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three months ended June 30, 2022 and 2021 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 2, 2022 |
Burcon Announces Fiscal 2023 First Quarter Conference Call to be Held on August 15, 2022 News Release Burcon Announces Fiscal 2023 First Quarter Conference Call to be Held on August 15, 2022 Vancouver, British Columbia, August 2, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Monday, August 15, 2022 at 5:00 p. |
|
| August 1, 2022 |
Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F for the fiscal year ended March 31, 2022 (the "Report") of Burcon NutraScience Corporation (the "Company"), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Sectio |
|
| August 1, 2022 |
B. Memorandum and articles of association Exhibit 99.5 - Additional Information Part I Item 3 D. Risk factors Our inability to provide audited financial statements for Merit Functional Foods Corporation in accordance with Rule 3-09 may result in enforcement actions by the SEC or may, among other matters, cause us to be unable to complete a public offering in the United States We have been unable to provide certain financial statements of |
|
| August 1, 2022 |
Exhibit 12.1 CERTIFICATION OF FORM 20-F REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Peter H. Kappel, certify that: 1. I have reviewed this annual report on Form 20-F for the fiscal year ended March 31, 2022 of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact |
|
| August 1, 2022 |
DESCRIPTION OF BURCON NUTRASCIENCE COMMON SHARES The common shares of Burcon NutraScience Corporation (the "Common Shares") are its only class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). |
|
| August 1, 2022 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report on Form 20-F for the fiscal year ended March 31, 2022 (the "Report") of Burcon NutraScience Corporation (the "Company"), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Sectio |
|
| August 1, 2022 |
Exhibit 12.2 CERTIFICATION OF FORM 20-F REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Jade Cheng, certify that: 1. I have reviewed this annual report on Form 20-F for the fiscal year ended March 31, 2022 of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or o |
|
| August 1, 2022 |
Audited Annual Consolidated Financial Statements for the fiscal year ended March 31, 2022. Burcon NutraScience Corporation Consolidated Financial StatementsMarch 31, 2022, 2021 and 2020 (In Canadian dollars) MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING Our management is responsible for establishing and maintaining adequate internal control over financial reporting in accordance with National Instrument 52-109 Certification of Disclosure in Issuers? Annual Filings and Rules 13a-15(f) under the U. |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F [ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OFTHE SECURITIES EXCHANGE ACT OF 1934 OR [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT |
|
| July 29, 2022 |
BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, British Columbia V6J 1Z2 Telephone: (604) 733-0896 Facsimile: (604) 733-8821 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO OUR SHAREHOLDERS: Burcon NutraScience Corporation's (the "Corporation" or "Burcon") Annual Meeting (the "Meeting") will be held on September 14, 2022, at 10:00 a. |
|
| July 29, 2022 | ||
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| July 29, 2022 | ||
| July 29, 2022 |
BURCON NUTRASCIENCE CORPORATION BURCON NUTRASCIENCE CORPORATION TO ALL REGISTERED AND TO NON-REGISTERED SHAREHOLDERS: National Instrument 51-102 Continuous Disclosure Obligations provides registered and beneficial securityholders with the opportunity to elect annually to have their name added to an issuer's supplemental mailing list in order to receive interim financial statements and related Management's Discussion & Analysis ("MD&A") of the Issuer. |
|
| July 29, 2022 |
NOTICE RE ANNUAL MEETING OF SHAREHOLDERS OF BURCON NUTRASCIENCE CORPORATION July 27, 2022 NOTICE RE ANNUAL MEETING OF SHAREHOLDERS OF BURCON NUTRASCIENCE CORPORATION NOTICE-AND-ACCESS Burcon NutraScience Corporation (the "Issuer," "us" or "we") will be holding its annual meeting (the "Meeting") of shareholders on Wednesday, September 14, 2022 at Pinnacle Hotel Harbourfront, 1133 West Hastings Street, Vancouver, BC V6E 3T3, Canada. |
|
| July 29, 2022 |
BURCON NUTRASCIENCE CORPORATION Notice of Annual Meeting of Shareholders to be held on September 14, 2022 Management Proxy Circular TABLE OF CONTENTS LETTER TO SHAREHOLDERS 1 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS 1 MANAGEMENT PROXY CIRCULAR 1 GENERAL PROXY INFORMATION 1 Who Can Vote 1 Obtaining a Paper Copy of Management Proxy Circular and Financial Statements 2 How You Can Vote 2 Distribution |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| July 28, 2022 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon JV, Merit Functional Foods Achieves Significant Innovation in a 100% Protein-Based Solution to Replace Methylcellulose in Meat Alternatives Merit's Peazazz Pea Protein Can Now Help Drive Clean Label Food and Beverage Applications Vancouver, British Columbia, July 28, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: |
|
| July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| July 26, 2022 |
Burcon to Present at the Canaccord Genuity 42nd Annual Growth Conference News Release Burcon to Present at the Canaccord Genuity 42nd Annual Growth Conference Vancouver, British Columbia, July 26, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it will present at the Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022 at 11:30am ET. |
|
| July 21, 2022 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon JV, Merit Functional Foods Launches New Peazazz C Pea Protein Ingredient Peazazz C Offers Exceptional Solubility and Unparalleled Smooth Creamy Texture Vancouver, British Columbia, July 21, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-base |
|
| July 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 30, 2022 |
June 30, 2022 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: BURCON NUTRASCIENCE CORPORATION Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General Meeting Record Date for Notice of Meeting : July 27, 2022 Record Date |
|
| June 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 29, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Colum |
|
| June 29, 2022 |
FORM 51-102F3 MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon" or the "Company") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change June 20, 2022. |
|
| June 29, 2022 |
Execution Version SENIOR SECURED LOAN AGREEMENT THIS AGREEMENT (this "Agreement") dated as of June 20, 2022 is between Burcon NutraScience Corporation (the "Borrower") and Large Scale Investments Limited (the "Lender"). |
|
| June 27, 2022 |
Burcon NutraScience Corporation Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2022, 2021 and 2020 (In Canadian dollars) MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING Our management is responsible for establishing and maintaining adequate internal control over financial reporting in accordance with National Instrument 52-109 Certification of Disclosure in Issuers’ Annual Filings and Rules 13a-15(f) under the U. |
|
| June 27, 2022 |
Form 52-109F1 Certification of annual filings - full certificate Form 52-109F1 Certification of annual filings - full certificate I, Peter H. Kappel, the Interim Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the "annua |
|
| June 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 27, 2022 |
BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, B.C. V6J 1Z2 CANADA Telephone: (604) 733-0896 Facsimile: (604) 733-8821 ANNUAL INFORMATION FORM FOR THE YEAR ENDED MARCH 31, 2022 June 27, 2022 TABLE OF CONTENTS PRELIMINARY NOTES 1 Effective Date of Information 1 Forward Looking Statements 1 Currency 4 Glossary 4 CORPORATE STRUCTURE 5 INTERCORPORATE RELATIONSHIPS 5 GENERAL DEVELOPMENT |
|
| June 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 27, 2022 |
Form 52-109F1 Certification of annual filings - full certificate Form 52-109F1 Certification of annual filings - full certificate I, Jade Cheng, the Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. |
|
| June 27, 2022 | ||
| June 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 27, 2022 |
Burcon Announces Fiscal 2022 Results and Reviews Operations News Release Burcon Announces Fiscal 2022 Results and Reviews Operations Vancouver, British Columbia, June 27, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal year ended March 31, 2022. |
|
| June 27, 2022 | ||
| June 27, 2022 |
EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Years ended March 31, 2022, 2021 and 2020 (All amounts following are expressed in Canadian dollars unless otherwise indicated.) This Management's Discussion and Analysis ("MD&A") has been prepared as at June 27, 2022 to provide a meaningful understanding of Burcon NutraScien |
|
| June 21, 2022 |
Burcon Announces Execution of $10 Million Loan Agreement News Release Burcon Announces Execution of $10 Million Loan Agreement Vancouver, British Columbia, June 21, 2022 - Burcon NutraScience Corporation ("Burcon" or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, announced today that it has entered into a loan agreement (the "Loan Agreement") pursuant to which Large Scale Investments Limited (the "Lender"), a wholly-owned subsidiary of Firewood Elite Limited ("Firewood"), will provide Burcon with a secured loan (the "Loan") of up to $10 million (the "Loan Amount"). |
|
| June 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 13, 2022 |
Burcon Announces Fiscal Year 2022 Conference Call To Be Held on June 27, 2022 EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Announces Fiscal Year 2022 Conference Call To Be Held on June 27, 2022 Vancouver, British Columbia, June 13, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and web |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addres |
|
| May 3, 2022 |
Burcon Announces $10 million Credit Facility from Shareholder News Release Burcon Announces $10 million Credit Facility from Shareholder Vancouver, British Columbia, May 3, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, announced today that it has signed a term sheet (the "Term Sheet") with its largest shareholder with respect to a proposed credit facility of up to $10 million to Burcon. |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addr |
|
| April 28, 2022 |
Burcon Updates on Developments EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Updates on Developments Vancouver, British Columbia, April 28, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to provide an update on its developments in light of the recent announcement of |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addr |
|
| April 7, 2022 |
News Release Burcon Receives Co-Investment from Protein Industries Canada to Develop Food-Grade High Purity Proteins from Sunflower Seeds Vancouver, British Columbia, April 7, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that it has received a co-investment from Proteins Industries Canada for the development of high-quality protein ingredients from sunflower seeds. |
|
| April 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addr |
|
| April 6, 2022 |
Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Receives NASDAQ Letter Regarding Minimum Bid Price Deficiency Vancouver, British Columbia, April 06, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, announced that on April 1, 2022, the Company received |
|
| March 3, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Colu |
|
| March 3, 2022 |
Burcon to Participate in Upcoming Investor Conferences News Release Burcon to Participate in Upcoming Investor Conferences Vancouver, British Columbia, March 3, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it will participate at two upcoming investor conferences from March 13 to 17, 2022: RO |
|
| March 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addr |
|
| March 2, 2022 |
FORM 51-102F3 MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon" or the "Company") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change March 1, 2022. |
|
| March 1, 2022 |
Burcon Announces Appointment of Peter H. Kappel as Interim CEO EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Announces Appointment of Peter H. Kappel as Interim CEO Vancouver, British Columbia, March 1, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to announce that Peter H. Kappel, Chairman of Bur |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Amendment No. 1 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Ca |
|
| March 1, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Colu |
|
| February 14, 2022 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and nine months ended December 31, 2021 and 2020 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| February 14, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British C |
|
| February 14, 2022 |
Burcon Reports Fiscal 2022 Third Quarter Results News Release Burcon Reports Fiscal 2022 Third Quarter Results Vancouver, British Columbia, February 14, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal third quarter ended December 31, 2021. |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| February 14, 2022 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate EX-99.4 5 exhibit99-4.htm EXHIBIT 99.4 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer") for the in |
|
| February 14, 2022 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. Tergesen, Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer") fo |
|
| February 14, 2022 |
Burcon NutraScience Corporation EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and nine months ended December 31, 2021 and 2020 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at December 31, 2021 and March 31, 2021 (in Canadian dollars) December 31, 2021 $ Marc |
|
| February 1, 2022 |
Burcon Announces Fiscal 2022 Third Quarter Conference Call to be Held on February 14, 2022 EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Announces Fiscal 2022 Third Quarter Conference Call to be Held on February 14, 2022 Vancouver, British Columbia, February 1, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor confere |
|
| February 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| January 26, 2022 |
BRCN / Burcon NutraScience Corp. / Chan Yiu Lun Alan - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Burcon NutraScience Corporation (Name of Issuer) Common Share without par value (Title of Class of Securities) 120831 10 2 (CUSIP Number) Chan Yiu Lun, Alan c/o 30th Floor, Bank of America Tower, 12 Harcourt Road, Central, Hong Kong +852 2831 8118 (Name, Address and Teleph |
|
| January 25, 2022 |
6-K 1 form6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Co |
|
| January 25, 2022 |
News Release Burcon Announces Expansion of Intellectual Property Portfolio Files Five Additional US Patent Applications Vancouver, British Columbia, January 25, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it has expanded its intellectual property portfolio through the filing of five additional US patent applications covering technologies for the production of sunflower seed protein and pulse proteins. |
|
| January 12, 2022 |
FORM 51-102F3 MATERIAL CHANGE REPORT EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon" or the "Company") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change January 10, 2022. Item 3: News Release A news release with respect to the material change described herein was disseminated on Januar |
|
| January 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Ad |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Ad |
|
| January 10, 2022 |
Burcon Announces CEO Transition News Release Burcon Announces CEO Transition Vancouver, British Columbia, January 10, 2022 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that Johann Tergesen will be stepping down as President and Chief Executive Officer. |
|
| November 22, 2021 |
Burcon to Participate in Upcoming Investor Conferences EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon to Participate in Upcoming Investor Conferences Vancouver, British Columbia, November 22, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it will participate at two upcoming investo |
|
| November 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 15, 2021 |
Burcon NutraScience Corporation Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and six months ended September 30, 2021 and 2020 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at September 30, 2021 and March 31, 2021 (in Canadian dollars) September 30, 2021 $ March 31, 2021 $ ASSETS Current assets Ca |
|
| November 15, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and six months ended September 30, 2021 and 2020 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| November 15, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. |
|
| November 15, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 15, 2021 |
Burcon Reports Fiscal 2022 Second Quarter Results News Release Burcon Reports Fiscal 2022 Second Quarter Results Vancouver, British Columbia, November 15, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal second quarter ended September 30, 2021. |
|
| November 12, 2021 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon JV, Merit Functional Foods' First-of-its-Kind Plant Protein Production Facility Commercially Ready Vancouver, British Columbia, November 10, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 8, 2021 |
News Release Burcon JV Company, Merit Functional Foods, Receives Co-Investment from Protein Industries Canada to Develop High-Quality Meat Alternatives Vancouver, British Columbia, November 8, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, is pleased to share that its joint venture company, Merit Functional Foods Corporation ("Merit Foods"), received a co-investment from Protein Industries Canada, which will see Merit Foods' best-in-class pea and canola protein ingredients incorporated into new high-quality plant-based meat alternative products. |
|
| November 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 4, 2021 |
Burcon to Participate in Upcoming Investor Conferences News Release Burcon to Participate in Upcoming Investor Conferences Vancouver, British Columbia, November 4, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it will participate at two upcoming investor conferences on November 16, 2021: Canaccord Genuity's Third Annual Health and Wellness Conference Presentation only ROTH Capital's 10th Annual Technology & AgTech Answers Virtual Event 1x1 meetings only For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR. |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| November 2, 2021 |
Burcon Announces Fiscal 2022 Second Quarter Conference Call to be Held on November 15, 2021 News Release Burcon Announces Fiscal 2022 Second Quarter Conference Call to be Held on November 15, 2021 Vancouver, British Columbia, November 2, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Monday, November 15, 2021 at 5:00 p. |
|
| September 21, 2021 |
Burcon Announces Board Change and Provides Business Update EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Announces Board Change and Provides Business Update Vancouver, British Columbia, September 21, 2021 - Burcon NutraScience Corporation (TSX: BU NASDAQ: BRCN), a global technology leader in the development of plant-based proteins for foods and beverages, announces that Mr. Peter H. Kappel has been appointed as chairman of Burcon's board of d |
|
| September 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 16, 2021 |
Burcon Announces Results of Shareholder Meeting Adds Alfred Lau to its Board of Directors News Release Burcon Announces Results of Shareholder Meeting Adds Alfred Lau to its Board of Directors Vancouver, British Columbia, September 16, 2021 - Burcon NutraScience Corporation (TSX: BU NASDAQ: BRCN) a global technology leader in the development of plant-based proteins, is pleased to announce the results from its 2021 annual and special meeting of shareholders (the "Meeting") held on September 15, 2021. |
|
| September 16, 2021 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 VIA SEDAR September 16, 2021 British Columbia Securities Commission Alberta Securities Commission Saskatchewan Securities Commission Manitoba Securities Commission Ontario Securities Commission Office of the Administrator of Securities, New Brunswick Nova Scotia Securities Commission The Toronto Stock Exchange Dear Sirs: Re: Burcon NutraScience Corporation - |
|
| September 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| September 9, 2021 |
Burcon Outlines In-Person AGM Venue Details, New Provincial Public Health Order Vaccine Requirements News Release Burcon Outlines In-Person AGM Venue Details, New Provincial Public Health Order Vaccine Requirements Vancouver, British Columbia, September 9, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, today announced that in accordance with the new Public Health Order ("PHO") guidance issued by the province of British Columbia, Burcon's in-person Annual and Special Meeting of shareholders ("AGM"), scheduled to take place at The Westin Bayshore Hotel in Vancouver on September 15, 2021, will require all attendees to provide proof of vaccination status. |
|
| September 2, 2021 |
Burcon to Participate at Raymond James Sustainability Conference on September 13-14, 2021 News Release Burcon to Participate at Raymond James Sustainability Conference on September 13-14, 2021 Vancouver, British Columbia, September 2, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, today announced that it will participate in a panel discussion at the inaugural Raymond James Sustainability Conference on September 14, 2021 at 12:30pm ET. |
|
| September 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 ( |
|
| August 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 26, 2021 |
Burcon to Participate at Exane BNP Paribas ESG Conference on September 7-9, 2021 EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon to Participate at Exane BNP Paribas ESG Conference on September 7-9, 2021 Vancouver, British Columbia, August 26, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, today announced that it wil |
|
| August 16, 2021 |
EX-99 3 exhibit99-2.htm EXHIBIT 99-2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three months ended June 30, 2021 and 2020 (All amounts following are expressed in Canadian dollars unless otherwise indicated.) This Management's Discussion and Analysis ("MD&A") has been prepared as at August 16, 2021 to provide a meaningful understanding of Burcon NutraScien |
|
| August 16, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate EX-99 5 exhibit99-4.htm EXHIBIT 99.4 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer") for the inte |
|
| August 16, 2021 |
Burcon NutraScience Corporation EX-99 2 exhibit99-1.htm EXHIBIT 99.1 Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three months ended June 30, 2021 and 2020 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at June 30, 2021 and March 31, 2021 (Prepared in Canadian dollars) June 30, 2021 $ March 31, 2021 $ A |
|
| August 16, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. |
|
| August 16, 2021 |
Burcon Reports Fiscal 2022 First Quarter Results News Release Burcon Reports Fiscal 2022 First Quarter Results Vancouver, British Columbia, August 16, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, reported results for the fiscal first quarter ended June 30, 2021. |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.1 TO FORM 40-F/A [ ] Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or [X] Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended March 31, 2021 Commission File Number Burcon NutraScience Corporation (Exact name of Reg |
|
| August 11, 2021 |
EXHIBIT 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 Burcon NutraScience Corporation (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its Annual Report on Form 40-F for the fiscal year ended March 31, 2021 (the "Report"). I, Jade Cheng, Chief Financial Officer of the Co |
|
| August 11, 2021 |
EXHIBIT 99.4 CERTIFICATION REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Johann F. Tergesen, certify that: 1. I have reviewed this Annual Report on Form 40-F of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make |
|
| August 11, 2021 |
Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2021 and 2020 (Prepared in Canadian dollars) Report of Independent Registered Public Accounting Firm To the Directors of Burcon NutraScience Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Burcon NutraScience Corporation and its subsidiaries (together, the Company) as of March 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive loss, changes in shareholders? equity and cash flows for the years then ended, including the related notes (collectively referred to as the consolidated financial statements). |
|
| August 11, 2021 |
EXHIBIT 99.5 CERTIFICATION REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Jade Cheng, certify that: 1. I have reviewed this Annual Report on Form 40-F of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| August 11, 2021 |
Consent of PricewaterhouseCoopers LLP Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in this Amended Annual Report on Form 40-F/A for the year ended March 31, 2021 of Burcon NutraScience Corporation of our report dated June 29, 2021, relating to the consolidated financial statements, which appears in Exhibit 99. |
|
| August 11, 2021 |
EXHIBIT 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 Burcon NutraScience Corporation (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its Annual Report on Form 40-F for the fiscal year ended March 31, 2021 (the "Report"). I, Johann F. Tergesen, President and Chief Execu |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 5, 2021 |
Burcon to Present at the Canaccord Genuity 41st Annual Growth Conference News Release Burcon to Present at the Canaccord Genuity 41st Annual Growth Conference Vancouver, British Columbia, August 5, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, today announced that it will present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 at 1:00pm ET. |
|
| August 4, 2021 |
NOTICE RE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS OF BURCON NUTRASCIENCE CORPORATION EX-99.2 3 exhibit99-2.htm EXHIBIT 99.2 July 28, 2021 NOTICE RE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS OF BURCON NUTRASCIENCE CORPORATION NOTICE-AND-ACCESS Burcon NutraScience Corporation (the "Issuer," "us" or "we") will be holding its annual and special meeting (the "Meeting") of shareholders on Wednesday, September 15, 2021 in the Marine Room at The Westin Bayshore, 1601 Bayshore Drive, Vanc |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 4, 2021 | ||
| August 4, 2021 |
BURCON NUTRASCIENCE CORPORATION Notice of Annual and Special Meeting of Shareholders to be held on September 15, 2021 Management Proxy Circular TABLE OF CONTENTS LETTER TO SHAREHOLDERS 1 Merit Functional Foods Joint Venture 1 Burcon R&D and Pipeline 2 Financing 3 Protection of Intellectual Property 3 NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS 1 MANAGEMENT PROXY CIRCULAR 1 GENERAL PROXY I |
|
| August 4, 2021 | ||
| August 4, 2021 |
EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, British Columbia V6J 1Z2 Telephone: (604) 733-0896 Facsimile: (604) 733-8821 NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO OUR SHAREHOLDERS: Burcon NutraScience Corporation's (the "Corporation" or "Burcon") Annual and Special Meeting (the "Meeting") will be held on September 15, 2021, at |
|
| August 4, 2021 |
BURCON NUTRASCIENCE CORPORATION EX-99.6 7 exhibit99-6.htm EXHIBIT 99.6 BURCON NUTRASCIENCE CORPORATION TO ALL REGISTERED AND TO NON-REGISTERED SHAREHOLDERS: National Instrument 51-102 Continuous Disclosure Obligations provides registered and beneficial securityholders with the opportunity to elect annually to have their name added to an issuer's supplemental mailing list in order to receive interim financial statements and relat |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Add |
|
| August 3, 2021 |
Burcon Announces Fiscal 2022 First Quarter Conference Call to be Held on August 16, 2021 News Release Burcon Announces Fiscal 2022 First Quarter Conference Call to be Held on August 16, 2021 Vancouver, British Columbia, August 3, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Monday, August 16, 2021 at 5:00 p. |
|
| July 8, 2021 |
BURCON ANNOUNCES APPOINTMENT OF JEANNE MCCAHERTY TO ITS BOARD OF DIRECTORS News Release BURCON ANNOUNCES APPOINTMENT OF JEANNE MCCAHERTY TO ITS BOARD OF DIRECTORS Vancouver, British Columbia, July 8, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, is pleased to announce that Ms. |
|
| July 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| June 30, 2021 |
Burcon Announces Fiscal 2021 Results and Reviews Operations EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon Announces Fiscal 2021 Results and Reviews Operations Vancouver, British Columbia, June 29, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, reported results for the fiscal year ended March 3 |
|
| June 29, 2021 |
EXHIBIT 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 Burcon NutraScience Corporation (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its Annual Report on Form 40-F for the fiscal year ended March 31, 2021 (the "Report"). I, Jade Cheng, Chief Financial Officer of the Co |
|
| June 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [ ] Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or [X] Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended March 31, 2021 Commission File Number Burcon NutraScience Corporation (Exact name of Registrant as specified |
|
| June 29, 2021 |
Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2021 and 2020 (Prepared in Canadian dollars) Report of Independent Registered Public Accounting Firm To the Directors of Burcon NutraScience Corporation Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Burcon NutraScience Corporation and its subsidiaries (together, the Company) as of March 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive loss, changes in shareholders? equity and cash flows for the years then ended, including the related notes (collectively referred to as the consolidated financial statements). |
|
| June 29, 2021 |
Consent of PricewaterhouseCoopers LLP Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in this Annual Report on Form 40-F for the year ended March 31, 2021 of Burcon NutraScience Corporation of our report dated June 29, 2021, relating to the consolidated financial statements, which appears in Exhibit 99. |
|
| June 29, 2021 |
EXHIBIT 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE U.S. SARBANES-OXLEY ACT OF 2002 Burcon NutraScience Corporation (the "Company") is filing with the U.S. Securities and Exchange Commission on the date hereof, its Annual Report on Form 40-F for the fiscal year ended March 31, 2021 (the "Report"). I, Johann F. Tergesen, President and Chief Execu |
|
| June 29, 2021 |
Annual Information Form of the Registrant for the year ended March 31, 2021 BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, B.C. V6J 1Z2 CANADA Telephone: (604) 733-0896 Facsimile: (604) 733-8821 ANNUAL INFORMATION FORM FOR THE YEAR ENDED MARCH 31, 2021 June 29, 2021 TABLE OF CONTENTS PRELIMINARY NOTES 1 Effective Date of Information 1 Forward Looking Statements 1 Currency 4 Glossary 4 CORPORATE STRUCTURE 5 INTERCORPORATE RELATIONSHIPS 5 GENERAL DEVELOPMENT |
|
| June 29, 2021 |
EXHIBIT 99.4 CERTIFICATION REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Johann F. Tergesen, certify that: 1. I have reviewed this Annual Report on Form 40-F of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make |
|
| June 29, 2021 |
Management's Discussion and Analysis of the Registrant for the years ended March 31, 2021 and 2020 EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Years ended March 31, 2021 and 2020 (All amounts following are expressed in Canadian dollars unless otherwise indicated.) This Management's Discussion and Analysis ("MD&A") has been prepared as at June 29, 2021 to provide a meaningful understanding of Burcon NutraScience Cor |
|
| June 29, 2021 |
EXHIBIT 99.5 CERTIFICATION REQUIRED BY RULE 13a-14(a) OR RULE 15d-14(a), PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Jade Cheng, certify that: 1. I have reviewed this Annual Report on Form 40-F of Burcon NutraScience Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the sta |
|
| June 14, 2021 |
Burcon Announces Fiscal Year 2021 Conference Call To Be Held on June 29, 2021 News Release Burcon Announces Fiscal Year 2021 Conference Call To Be Held on June 29, 2021 Vancouver, British Columbia, June 14, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Tuesday, June 29, 2021 at 5:00 p. |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| May 28, 2021 |
News Release Burcon JV Company, Merit Functional Foods, Receives Second Co-Investment from Protein Industries Canada Vancouver, British Columbia, May 28, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, is pleased to share that its joint venture company, Merit Functional Foods Corporation ("Merit Foods") received a second co-investment from Protein Industries Canada, which will see Merit Foods' game-changing pea and canola protein ingredients utilized in new plant-based products. |
|
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addres |
|
| May 26, 2021 |
Burcon to Begin Trading on NASDAQ EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Burcon to Begin Trading on NASDAQ Vancouver, British Columbia, May 24, 2021 - Burcon NutraScience Corporation ("Burcon or the "Company") (TSX: BU) (NASDAQ: BRCN) (OTCQB: BUROF), a global technology leader in the development of clean-label, plant-based proteins for foods and beverages, is pleased to announce the Company's common stock has been app |
|
| May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2021 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addre |
|
| May 17, 2021 |
News Release dated May 4, 2020 EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 News Release Merit Functional Foods Expanding Production Capacity Arranges $85 Million Debt Financing Package Vancouver, May 4, 2020 / - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, is pleased to announce that its joint venture company, Merit Functional Foods Corporati |
|
| May 17, 2021 | ||
| May 17, 2021 |
News Release dated March 4, 2021 EX-99.45 46 exhibit99-45.htm EXHIBIT 99.45 News Release Burcon to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021 Vancouver, British Columbia, March 4, 2021 - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BUROF) a global technology leader in the development of plant-based proteins, today announced that it will participate in the 33rd Annual ROTH Conference, which will be he |
|
| May 17, 2021 |
EX-99.22 23 exhibit99-22.htm EXHIBIT 99.22 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. Tergesen, Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer" |
|
| May 17, 2021 |
EX-99.24 25 exhibit99-24.htm EXHIBIT 99.24 |
|
| May 17, 2021 |
News Release dated June 22, 2020 EX-99.5 6 exhibit99-5.htm EXHIBIT 99.5 News Release Burcon JV Company Merit Functional Foods Secures Additional $10 Million Funding Vancouver, June 22, 2020 / - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, is pleased to announce that its joint venture company, Merit Functional Foods Corporation ("Merit Func |
|
| May 17, 2021 |
Consent of PricewaterhouseCoopers LLP EX-99.49 50 exhibit99-49.htm EXHIBIT 99.49 Consent of Independent Auditor We hereby consent to the inclusion in the Registration Statement on Form 40-F of Burcon NutraScience Corporation of our report dated June 29, 2020, relating to the consolidated financial statements of Burcon NutraScience Corporation, which appears in Exhibit 99.6 of this Registration Statement. We also consent to the referen |
|
| May 17, 2021 |
Certificate of Continuation of Registrant EX-99.47 48 exhibit99-47.htm EXHIBIT 99.47 |
|
| May 17, 2021 |
News Release dated February 9, 2021 News Release Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production Vancouver, British Columbia, February 9, 2021 - Burcon NutraScience Corporation (TSX: BU OTCQB: BUROF) a global technology leader in the development of plant-based proteins, is pleased to announce that its joint venture company, Merit Functional Foods Corporation ("Merit Foods" or "Merit") has completed the first commercial production runs of Peazazz? and Peazac? pea proteins at its state-of-the-art plant protein production facility in Manitoba, Canada, dedicated to the production, under license, of Burcon's novel pea and canola protein ingredients. |
|
| May 17, 2021 |
News Release dated September 2, 2020 EX-99.27 28 exhibit99-27.htm EXHIBIT 99.27 News Release Burcon Provides Business Update and Notice to Convertible Debenture Holders Vancouver, September 2, 2020 / - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, is pleased to provide further updates with respect to its activities and announces the forced conv |
|
| May 17, 2021 |
News Release dated August 27, 2020 EX-99.26 27 exhibit99-26.htm EXHIBIT 99.26 News Release Burcon JV Company, Merit Functional Foods, Partners with Bunge to Bring Pea and Canola Protein to Market Vancouver, August 27, 2020 - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, is pleased to announce that its joint venture company, Merit Functional F |
|
| May 17, 2021 |
News Release dated April 12, 2021 EX-99.46 47 exhibit99-46.htm EXHIBIT 99.46 News Release Burcon JV Company, Merit Functional Foods, Achieves First Commercial Production of Canola Protein A Global Plant-based Protein First For Canola Vancouver, British Columbia, April 12, 2021 - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BUROF), a global technology leader in the development of clean-label, plant-based proteins for foods and |
|
| May 17, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and nine months ended December 31, 2020 and 2019 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| May 17, 2021 |
EXECUTION VERSION [personal information redacted] ("Party A") and [personal information redacted] ("Party B") and BURCON NUTRASCIENCE HOLDINGS CORP. |
|
| May 17, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three months ended June 30, 2020 and 2019 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| May 17, 2021 |
EX-99.2 3 exhibit99-2.htm EXHIBIT 99.2 Burcon NutraScience Holdings Corp. 1946 West Broadway Vancouver, BC V6J 1Z2 April 21, 2020 Merit Functional Foods Corporation 1601 C Silver Avenue Winnipeg, Manitoba R3J 4A1 Attention: Ryan Bracken and Barry Tomiski Re: LC and Loan in the Amount of C$6,500,000 We are pleased to confirm that we are prepared to procure the LC (as defined below) and to make a lo |
|
| May 17, 2021 |
Voting Instruction Form for Meeting of Shareholders to be held on September 17, 2020 EX-99.17 18 exhibit99-17.htm EXHIBIT 99.17 |
|
| May 17, 2021 |
News Release dated June 29, 2020 EX-99.11 12 exhibit99-11.htm EXHIBIT 99.11 News Release Burcon Announces Fiscal 2020 Results and Reviews Operations Vancouver, British Columbia, June 29, 2020 - Burcon NutraScience Corporation (TSX: BU; OTCQB: BUROF), a global leader in developing functionally and nutritionally valuable plant-proteins, reported results for the year ended March 31, 2020. "Fiscal 2020 was truly a transformational ye |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing ("Filer"): Burcon NutraScience Corporation B. (1) This is (check one): ? An original filing for the Filer. ? An amended filing for the Filer. (2) Check the following box if you are filing the Form F-X in paper in accordance |
|
| May 17, 2021 |
Management Information Circular of Burcon NutraScience Corporation dated July 30, 2020 BURCON NUTRASCIENCE CORPORATION Notice of Annual and Special Meeting of Shareholders to be held on September 17, 2020 Management Proxy Circular TABLE OF CONTENTS LETTER TO SHAREHOLDERS 1 NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS 1 MANAGEMENT PROXY CIRCULAR 1 GENERAL PROXY INFORMATION 1 Who Can Vote 1 Obtaining a Paper Copy of Management Proxy Circular and Financial Statements 2 Attendin |
|
| May 17, 2021 |
Notice of Meeting of Shareholders dated July 30, 2020 EX-99.14 15 exhibit99-14.htm EXHIBIT 99.14 July 30, 2020 NOTICE RE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS OF BURCON NUTRASCIENCE CORPORATION NOTICE-AND-ACCESS Burcon NutraScience Corporation (the "Issuer," "us" or "we") will be holding its annual and special meeting (the "Meeting") of shareholders on Thursday, September 17, 2020 held virtually via live webcast. A notice of meeting and manageme |
|
| May 17, 2021 |
EX-99.8 9 exhibit99-8.htm EXHIBIT 99.8 Form 52-109F1 Certification of annual filings - full certificate I, Jade Cheng, the Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the |
|
| May 17, 2021 |
Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2020 and 2019 (Prepared in Canadian dollars) Independent auditor?s report To the Shareholders of Burcon NutraScience Corporation Our opinion In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of Burcon NutraScience Corporation and its subsidiaries (together, the Company) as at March 31, 2020 and 2019, and its financial performance and its cash flows for the years then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS). |
|
| May 17, 2021 |
Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and nine months ended December 31, 2020 and 2019 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at December 31, 2020 and March 31, 2020 (Prepared in Canadian dollars) December 31, 2020 $ March 31, 2020 $ ASSETS Current as |
|
| May 17, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. |
|
| May 17, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and six months ended September 30, 2020 and 2019 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| May 17, 2021 |
Material Change Report dated August 17, 2020 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change August 7, 2020. |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F [X] Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 or [ ] Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended Commission File Number Burcon NutraScience Corporation (Exact name of Registrant as specified in its charter |
|
| May 17, 2021 |
EX-99.9 10 exhibit99-9.htm EXHIBIT 99.9 Form 52-109F1 Certification of annual filings - full certificate I, Johann F. Tergesen, the Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by referen |
|
| May 17, 2021 |
Report of Voting Results of the Annual Meeting of Shareholders held on September 17, 2020 EX-99.32 33 exhibit99-32.htm EXHIBIT 99.32 VIA SEDAR September 18, 2020 British Columbia Securities Commission Alberta Securities Commission Saskatchewan Securities Commission Manitoba Securities Commission Ontario Securities Commission Office of the Administrator of Securities, New Brunswick Nova Scotia Securities Commission The Toronto Stock Exchange Dear Sirs: Re: Burcon NutraScience Corporatio |
|
| May 17, 2021 |
BURCON NUTRASCIENCE CORPORATION - and - BURCON NUTRASCIENCE (MB) CORP. - and - MERIT FUNCTIONAL FOODS CORPORATION AMENDED AND RESTATED LICENSE AND PRODUCTION AGREEMENT TABLE OF CONTENTS SECTION PAGE ARTICLE 1 INTERPRETATION - 1 - Section 1.1 Definitions - 1 - Section 1.2 Interpretation - 8 - Section 1.3 Fair Market Value - 9 - ARTICLE 2 COMMERCIALIZATION AND PRODUCTION - 10 - Section 2.1 Developme |
|
| May 17, 2021 |
EX-99.19 20 exhibit99-19.htm EXHIBIT 99.19 Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three months ended June 30, 2020 and 2019 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at June 30, 2020 and March 31, 2020 (Prepared in Canadian dollars) June 30, 2020 $ March 31, 20 |
|
| May 17, 2021 |
EX-99.42 43 exhibit99-42.htm EXHIBIT 99.42 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer") for th |
|
| May 17, 2021 |
News Release dated December 7, 2020 EX-99.37 38 exhibit99-37.htm EXHIBIT 99.37 News Release Burcon to Participate in the Roth Deer Valley Virtual Consumer Conference Vancouver, British Columbia, December 7, 2020 - Burcon NutraScience Corporation (TSX: BU OTCQB: BUROF) a global technology leader in the development of plant-based proteins, is scheduled to participate in the Roth Virtual Deer Valley Conference. President and CEO Johann |
|
| May 17, 2021 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. |
|
| May 17, 2021 |
Form of Proxy for Meeting to be held on September 17, 2020 EX-99.16 17 exhibit99-16.htm EXHIBIT 99.16 |
|
| May 17, 2021 |
Notice of Meeting of Shareholders dated July 3, 2020 EX-99.12 13 exhibit99-12.htm EXHIBIT 99.12 July 03, 2020 510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: BURCON NUTRASCIENCE CORPORATION Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General and Special Meeting Record |
|
| May 17, 2021 |
Annual Information Form of Burcon NutraScience Corporation for the year ended March 31, 2020 BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, B.C. V6J 1Z2 Telephone: (604) 733-0896 Facsimile: (604) 733-8821 ANNUAL INFORMATION FORM FOR THE YEAR ENDED MARCH 31, 2020 June 29, 2020 TABLE OF CONTENTS PRELIMINARY NOTES 1 Effective Date of Information 1 Forward Looking Statements 1 Currency 4 Glossary 4 CORPORATE STRUCTURE 5 INTERCORPORATE RELATIONSHIPS 5 GENERAL DEVELOPMENT OF THE |
|
| May 17, 2021 |
Guarantee dated April 24, 2020 between Burcon NutraScience Corporation and Export Development Canada GUARANTEE THIS GUARANTEE is dated as of the 24th day of April, 2020. BETWEEN: BURCON NUTRASCIENCE CORPORATION (the "Guarantor") - and - EXPORT DEVELOPMENT CANADA (the "Lender") CONTEXT: A. Pursuant to a Loan Agreement dated as of April 24, 2020, between Merit Functional Foods Corporation, as borrower (the "Borrower") and the Lender, as subordinate lender, and Export Development Canada, as senior l |
|
| May 17, 2021 |
EX-99.33 34 exhibit99-33.htm EXHIBIT 99.33 Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and six months ended September 30, 2020 and 2019 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at September 30, 2020 and March 31, 2020 (Prepared in Canadian dollars) September |
|
| May 17, 2021 |
Material Change Report dated September 4, 2020 EX-99.28 29 exhibit99-28.htm EXHIBIT 99.28 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change August 27, 2020. Item 3: News Release A news release with respect to the material change described herein was disseminated on August 27, 2020 thro |
|
| May 17, 2021 |
EX-99.25 26 exhibit99-25.htm EXHIBIT 99.25 TERMINATION OF LICENSE AND PRODUCTION AGREEMENT This Termination of License and Production Agreement is made as of the 7th day of August, 2020 by Burcon Nutrascience Corporation, a Territory of Yukon corporation, having its principal place of business 1946 West Broadway, Vancouver, British Columbia, V6J 1Z2, and Burcon Nutrascience (MB) Corp., a Manitoba |
|
| May 17, 2021 |
News Release dated February 16, 2021 EX-99.44 45 exhibit99-44.htm EXHIBIT 99.44 News Release Burcon Reports Fiscal 2021 Third Quarter Results Vancouver, British Columbia, February 16, 2021 - Burcon NutraScience Corporation (TSX: BU OTCQB: BUROF) a global technology leader in the development of plant-based proteins, reported results for the fiscal third quarter ended December 31, 2020. Operational highlights for the third quarter ende |
|
| May 17, 2021 |
EX-99.43 44 exhibit99-43.htm EXHIBIT 99.43 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Johann F. Tergesen, Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer" |
|
| May 17, 2021 |
News Release dated September 18, 2020 EX-99.31 32 exhibit99-31.htm EXHIBIT 99.31 News Release Burcon Announces Results of Shareholder Meeting Vancouver, British Columbia, September 18, 2020 - Burcon NutraScience Corporation (TSX: BU OTCQB: BUROF) a global technology leader in the development of plant-based proteins, is pleased to announce the results from its 2020 annual meeting of shareholders (the "Meeting") held on September 17, 20 |
|
| May 17, 2021 |
Guarantee dated April 24, 2020 between Burcon NutraScience Corporation and Export Development Canada EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 GUARANTEE THIS GUARANTEE is dated as of the 24th day of April, 2020. BETWEEN: BURCON NUTRASCIENCE CORPORATION (the "Guarantor") - and - EXPORT DEVELOPMENT CANADA (the "Lender") CONTEXT: A. Pursuant to a Loan Agreement dated as of April 24, 2020, between Merit Functional Foods Corporation, as borrower (the "Borrower") and the Lender, as senior lender, and Expo |
|
| May 17, 2021 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Years ended March 31, 2020 and 2019 (All amounts following are expressed in Canadian dollars unless otherwise indicated. |
|
| May 17, 2021 |
News Release dated January 29, 2021 EX-99.38 39 exhibit99-38.htm EXHIBIT 99.38 News Release Burcon Announces Third Quarter 2021 Conference Call and Business Update To Be Held on February 16, 2021 Vancouver, British Columbia, January 29, 2021 - Burcon NutraScience Corporation (TSX: BU OTCQB: BUROF) a global technology leader in the development of plant-based proteins, will hold an investor conference call and webcast on Tuesday, Febr |
|
| May 17, 2021 |
EX-99.21 22 exhibit99-21.htm EXHIBIT 99.21 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of Burcon NutraScience Corporation (the "issuer") for th |
|
| May 17, 2021 |
News Release dated August 10, 2020 News Release Burcon Agrees to Terminate Clarisoy License Agreement with ADM Vancouver, August 10, 2020 / - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, announced today that Burcon and ADM have agreed to terminate the license and production agreement dated March 4, 2011 made among Burcon, Burcon NutraScience (MB) Corp. |
|
| May 17, 2021 |
News Release dated July 6, 2020 EX-99.13 14 exhibit99-13.htm EXHIBIT 99.13 News Release BURCON ANNOUNCES APPOINTMENT OF DEBORA FANG TO ITS BOARD OF DIRECTORS Vancouver, July 6, 2020 / - Burcon NutraScience Corporation ("Burcon") (TSX:BU, OTCQB:BUROF), a global technology leader in the development of plant-based proteins, is pleased to announce that Ms. Debora Fang has been appointed to its board of directors. Ms. Fang has 20 yea |
|
| May 23, 2019 |
BUR / Burcon NutraScience Corp. F-7 - - FORM F-7 As filed with the Securities and Exchange Commission on May 23, 2019 Registration Statement No. |
|
| May 23, 2019 |
Burcon NutraScience Corporation: Exhibit 2.3 - Filed by newsfilecorp.com Burcon NutraScience Corporation Condensed Consolidated Interim Financial Statements Three and nine months ended December 31, 2018 and 2017 (Unaudited) (Prepared in Canadian dollars) BURCON NUTRASCIENCE CORPORATION Condensed Consolidated Interim Balance Sheets (Unaudited) As at December 31, 2018 and March 31, 2018 (Prepared in |
|
| May 23, 2019 |
Burcon Nutrascience Corporation: Exhibit 2.5 - Filed by newsfilecorp.com BURCON NUTRASCIENCE CORPORATION Notice of Annual and Special Meeting of Shareholders to be held on September 6, 2018 Management Proxy Circular TABLE OF CONTENTS LETTER TO SHAREHOLDERS 1 NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS I MANAGEMENT PROXY CIRCULAR 1 GENERAL PROXY INFORMATION 1 WHO CAN VOTE 1 OBTAINING A PAP |
|
| May 23, 2019 |
Consent of PricewaterhouseCoopers LLP Burcon NutraScience Corporation: Exhibit 3.1 - Filed by newsfilecorp.com CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the use in this Registration Statement on Form F-7 of Burcon NutraScience Corporation of our report dated June 18, 2018 relating to the financial statements, which appears in this Registration Statement. “PricewaterhouseCoopers LLP” (signed) Pricewa |
|
| May 23, 2019 |
Burcon NutraScience Corporation: Exhibit 2.4 - Filed by newsfilecorp.com MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Three and nine months ended December 31, 2018 and 2017 (All amounts following are expressed in Canadian dollars unless otherwise indicated.) This Management’s Discussion and Analysis (“MD&A”) has been prepared as at February 14, 2019 to prov |
|
| May 23, 2019 |
BURCON NUTRASCIENCE CORPORATION: Exhibit 2.1 - Filed by newsfilecorp.com Burcon NutraScience Corporation Consolidated Financial Statements March 31, 2018 and 2017 (Prepared in Canadian dollars) June 18, 2018 Independent Auditor’s Report To the Shareholders of Burcon NutraScience Corporation We have audited the accompanying consolidated financial statements of Burcon NutraScience Corporation and it |
|
| May 23, 2019 |
Press release dated May 23, 2019 Burcon NutraScience Corporation: Exhibit 3.1 - Filed by newsfilecorp.com BURCON ANNOUNCES RIGHTS OFFERING DETAILS INSIDER PARTICIPATION Vancouver, British Columbia, May 23, 2019 – Burcon NutraScience Corporation (TSX:BU) ("Burcon") is pleased to announce that it will be offering rights (the "Rights Offering") to holders of its common shares ("Common Shares") of record at the close of business on M |
|
| May 23, 2019 |
Annual Information Form for the year ended March 31, 2018 BURCON NUTRASCIENCE CORPORATION 1946 West Broadway Vancouver, B.C. V6J 1Z2 Telephone: (604) 733-0896 Facsimile: (604) 733-8821 ANNUAL INFORMATION FORM FOR THE YEAR ENDED MARCH 31, 2018 June 18, 2018 TABLE OF CONTENTS PRELIMINARY NOTES 1 Effective Date of Information 1 Forward Looking Statements 1 Currency 4 Glossary 4 CORPORATE STRUCTURE 5 INTERCORPORATE RELATIONSHIPS 5 GENERAL DEVELOPMENT OF THE |
|
| May 23, 2019 |
Burcon Nutrascience Corporation: Exnibit 2.2 - Filed by newsfilecorp.com MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Years ended March 31, 2018 and 2017 (All amounts following are expressed in Canadian dollars unless otherwise indicated.) This Management’s Discussion and Analysis (“MD&A”) has been prepared as at June 18, 2018 to provide a meaningful unders |
|
| June 15, 2018 |
BUR / Burcon NutraScience Corp. FORM 15-12B Burcon NutraScience Corporation: Form 15-12B - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001 |
|
| June 4, 2018 |
BUR / Burcon NutraScience Corp. FORM 25 Burcon NutraScience Corporation - Form 25 - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35289 BURCON NUTRASCIENCE CORPORATION NASDAQ Capital Market (Exact name of Issuer as specified in its chart |
|
| May 25, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addres |
|
| May 25, 2018 |
Burcon Announces Intention to File Form 25 EXHIBIT 99.1 Burcon Announces Intention to File Form 25 VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation technologies, announced today that in order to complete the expected delisting of its common shares, the Company intends to file a Fo |
|
| April 25, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (Addr |
|
| April 25, 2018 |
Burcon Announces Delisting From Nasdaq Capital Market EXHIBIT 99.1 Burcon Announces Delisting From Nasdaq Capital Market VANCOUVER, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation technologies, announced today that it received a letter, dated April 25, 2018, from the Nasdaq Hearings Panel (the “Pane |
|
| February 27, 2018 |
EdgarFiling EXHIBIT 99.1 Burcon Announces Receipt of Nasdaq Letter Regarding Deficiency in Compliance With Certain Listing Rules VANCOUVER, British Columbia, Feb. 27, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (?Burcon? or the ?Company?), a leader in natural product extraction, purification and isolation technologies, announced that on February 21, 2018, the Comp |
|
| February 27, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| February 20, 2018 |
FORM 51-102F3 MATERIAL CHANGE REPORT Burcon NutraScience Corporation : Exhibit 99.1 - Filed by newsfilecorp.com FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Company Burcon NutraScience Corporation ("Burcon") 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 Item 2: Date of Material Change February 14, 2018. Item 3: News Release A news release with respect to the material change described herein was di |
|
| February 20, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) Burcon NutraScience Corporation : Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant?s name into En |
|
| February 20, 2018 |
EdgarFiling EXHIBIT 99.1 Burcon Congratulates Protein Industries Canada Plant Protein Industry ? To Share in $950 Million Innovation Superclusters Program VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (?Burcon? or the ?Corporation?), a leader in natural product extraction, purification and isolation technologies, congratulates P |
|
| February 20, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| February 20, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| February 20, 2018 |
Burcon Announces Details of Completed Rights Offering EdgarFiling EXHIBIT 99.1 Burcon Announces Details of Completed Rights Offering VANCOUVER, British Columbia, Feb. 19, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) ("Burcon") is pleased to announce that, further to its press release dated February 14, 2018 with respect to the completion of Burcon's rights offering (the "Rights Offering"), Burcon has issued 6,114,361 |
|
| February 14, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 Commission File Number: 001-35289 Burcon NutraScience Corporation (Translation of registrant's name into English) 1946 West Broadway Vancouver, British Columbia, Canada V6J 1Z2 (A |
|
| February 14, 2018 |
Burcon Announces Completion of Rights Offering EdgarFiling EXHIBIT 99.1 Burcon Announces Completion of Rights Offering VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) ("Burcon" or the "Company") is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00pm (EST) on February 13, 2018. The Rights Offering will result in the issuanc |
|
| February 9, 2018 |
BUR / Burcon NutraScience Corp. FORM 6-K (Current Report of Foreign Issuer) Burcon NutraScience Corporation - Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2018 Commission File Number: 001-35289 BURCON NUTRASCIENCE CORPORATION (Translation of registrant?s name into En |
|
| February 9, 2018 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate Burcon NutraScience Corporation - Exhibit 99.4 - Filed by newsfilecorp.com Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Jade Cheng, Chief Financial Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the ?interim filings?) of Burcon NutraScience C |
|
| February 9, 2018 |
Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate EX-99.3 4 exhibit99-3.htm EXHIBIT 99.3 Burcon NutraScience Corporation Form 52-109F2 Certification of Interim Filings Full Certificate I, Allan Yap, Chief Executive Officer of Burcon NutraScience Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Burcon NutraScience Corporation (the “issuer”) for the int |
